Intelligent Bio Solutions Inc. (INBS)
NASDAQ: INBS · IEX Real-Time Price · USD
1.530
-0.080 (-4.97%)
At close: Jul 19, 2024, 4:00 PM
1.590
+0.060 (3.92%)
Pre-market: Jul 22, 2024, 8:57 AM EDT
Intelligent Bio Solutions Employees
Intelligent Bio Solutions had 51 employees as of June 30, 2023. The number of employees increased by 39 or 325.00% compared to the previous year.
Employees
51
Change (1Y)
39
Growth (1Y)
325.00%
Revenue / Employee
$63,000
Profits / Employee
-$196,695
Market Cap
4.77M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| IM Cannabis | 95 |
| Biofrontera | 85 |
| Sharps Technology | 57 |
| Processa Pharmaceuticals | 13 |
| Adial Pharmaceuticals | 7 |
| Artelo Biosciences | 6 |
| Creative Medical Technology Holdings | 4 |
| Evoke Pharma | 4 |
INBS News
- 4 days ago - Intelligent Bio Solutions Inc. Advances on FDA 510(k) Pathway with Biocompatibility Study Success - GlobeNewsWire
- 24 days ago - Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results - GlobeNewsWire
- 25 days ago - Intelligent Bio Solutions Expands Presence in the UK Retail Sector with Major Account Acquisitions - GlobeNewsWire
- 4 weeks ago - Intelligent Bio Solutions Begins Subject Dosing and Sampling for FDA 510(k) Pharmacokinetic (PK) Study for its Intelligent Fingerprinting Drug Screening Technology - GlobeNewsWire
- 5 weeks ago - Intelligent Bio Solutions Adds Major European Transport and Infrastructure Solutions Provider to Growing Number of Accounts Adopting Fingerprint Drug Screening Technology - GlobeNewsWire
- 6 weeks ago - Intelligent Bio Solutions to Participate in the Sidoti Small-Cap Conference on June 12-13, 2024 - GlobeNewsWire
- 7 weeks ago - Intelligent Bio Solutions Successfully Completes Recruitment and Begins Subject Screening for FDA 510(k) Pharmacokinetic (PK) Study - GlobeNewsWire
- 2 months ago - Intelligent Bio Solutions Unveils Key Performance Indicator Growth in the United Kingdom as Drug Screening Industry Combats Drug Test Cheating and Searches for Simpler, Faster, Non-Invasive and More Cost-Effective Solutions - GlobeNewsWire